Hemodynamic Monitoring Systems Market Report 2026

The hemodynamic monitoring systems market size has grown strongly in recent years. It will grow from $1.67 billion in 2025 to $1.79 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increasing number of critical care admissions, expansion of intensive care units, rising adoption of invasive monitoring techniques, technological improvements in sensor accuracy, increased clinician awareness.

The hemodynamic monitoring systems market size is expected to see strong growth in the next few years. It will grow to $2.42 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing demand for remote patient monitoring, rising adoption of ai-assisted clinical decision support, expansion of minimally invasive monitoring solutions, growing focus on early shock detection, increasing investments in advanced monitoring systems. Major trends in the forecast period include increasing adoption of non-invasive monitoring techniques, rising integration of real-time data analytics, growing use of portable hemodynamic monitors, expansion of critical care monitoring applications, enhanced focus on early hemodynamic intervention.

The rising prevalence of cardiovascular diseases is expected to drive the growth of the hemodynamic monitoring systems market in the coming years. Cardiovascular diseases are a group of conditions affecting the heart and blood vessels. Hemodynamic monitoring systems provide real-time data and insights into a patient’s cardiovascular status, allowing healthcare professionals to make timely, accurate interventions, optimize treatment strategies, and improve patient outcomes. For example, in March 2024, the Government of the United Kingdom reported that in the financial year ending in 2023, slightly over 1,862,500 people in England, representing 3% of the population, had a GP diagnosis of coronary heart disease (CHD). Consequently, the increasing prevalence of cardiovascular diseases is fueling demand for hemodynamic monitoring systems.

Key companies in the hemodynamic monitoring systems market are focusing on developing advanced solutions to improve patient outcomes, enhance accuracy in cardiovascular assessments, and enable real-time data analysis for better clinical decision-making in critical care. The FloTrac Sensor is a minimally invasive device designed for continuous hemodynamic monitoring in critically ill patients. It provides real-time measurements of cardiac output and other hemodynamic parameters through arterial waveform analysis via a standard arterial catheter. For instance, in June 2023, Mindray Medical International Ltd., a China-based company, partnered with Edwards Lifesciences, a U.S.-based company, to launch a hemodynamic monitoring solution incorporating the FloTrac™ sensor. This sensor connects to an arterial line and automatically calculates critical hemodynamic parameters, including Cardiac Output (CO), Stroke Volume (SV), Stroke Volume Variation (SVV), Systemic Vascular Resistance (SVR), and Mean Arterial Pressure (MAP) every 20 seconds. Mindray’s BeneVision N series patient monitors serve as the platform for this integration.

In August 2023, Exor N.V., a Netherlands-based company, acquired Philips for $2.8 billion. Through this acquisition, Exor aims to expand its portfolio by leveraging Philips’ expertise in providing hemodynamic monitoring systems. Koninklijke Philips NV, also based in the Netherlands, is a provider of hemodynamic monitoring systems.

Major companies operating in the hemodynamic monitoring systems market are Abbott Laboratories, Medtronic Plc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Baxter International Inc., CNSystems Medizintechnik GmbH, Edwards Lifesciences Corporation, Drägerwerk AG & Co. KGaA, Getinge AB, ICU Medical Inc., Masimo Corporation, N.I. Medical Ltd., Nihon Kohden Corporation, Deltex Medical Group plc, CareTaker Medical, Osypka Medical GmbH, Cnoga Digital Care, Tensys Medical Inc., Uscom Limited, Shenzhen Keman Medical Equipment Co. Ltd., Schwarzer Cardiotek GmbH, EMTEL Śliwa sp. k.

North America was the largest region in the hemodynamic monitoring systems market in 2025. The regions covered in the hemodynamic monitoring systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hemodynamic monitoring systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the hemodynamic monitoring systems market by increasing costs of imported sensors, monitors, catheters, electronic components, and software-enabled hardware systems. Hospitals and cath labs in North America and Europe are most affected due to reliance on imported high-precision devices, while Asia-Pacific faces higher costs for system integration and upgrades. These tariffs are increasing capital equipment expenditures and delaying replacement cycles. However, they are also driving local assembly, regional sourcing of components, and innovation in cost-optimized monitoring solutions.

The hemodynamic monitoring systems market research report is one of a series of new reports that provides hemodynamic monitoring systems market statistics, including hemodynamic monitoring systems industry global market size, regional shares, competitors with a hemodynamic monitoring systems market share, detailed hemodynamic monitoring systems market segments, market trends and opportunities, and any further data you may need to thrive in the hemodynamic monitoring systems industry. This hemodynamic monitoring systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Hemodynamic monitoring systems are medical devices and techniques used to measure and evaluate physiological parameters related to cardiovascular function. These systems provide real-time insights into blood circulation, cardiac output, and other critical parameters within the circulatory system.

The primary product types of hemodynamic monitoring systems include monitors and consumables. Monitors refer to electronic devices and equipment that display and record a patient’s cardiovascular parameters. The main technique types include invasive and non-invasive methods. These systems are used by a variety of end-users, including hospitals, catheterization (Cath) labs, and other healthcare facilities.

The hemodynamic monitoring systems market consists of sales of central venous pressure (CVP) monitoring systems, pulmonary artery catheters, and accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.